170 related articles for article (PubMed ID: 10417202)
1. Fluorescent labels influence phagocytosis of Bordetella pertussis by human neutrophils.
Weingart CL; Broitman-Maduro G; Dean G; Newman S; Peppler M; Weiss AA
Infect Immun; 1999 Aug; 67(8):4264-7. PubMed ID: 10417202
[TBL] [Abstract][Full Text] [Related]
2. Bordetella pertussis virulence factors affect phagocytosis by human neutrophils.
Weingart CL; Weiss AA
Infect Immun; 2000 Mar; 68(3):1735-9. PubMed ID: 10679000
[TBL] [Abstract][Full Text] [Related]
3. Neutralizing antibodies to adenylate cyclase toxin promote phagocytosis of Bordetella pertussis by human neutrophils.
Weingart CL; Mobberley-Schuman PS; Hewlett EL; Gray MC; Weiss AA
Infect Immun; 2000 Dec; 68(12):7152-5. PubMed ID: 11083845
[TBL] [Abstract][Full Text] [Related]
4. Phagocytosed Bordetella pertussis fails to survive in human neutrophils.
Lenz DH; Weingart CL; Weiss AA
Infect Immun; 2000 Feb; 68(2):956-9. PubMed ID: 10639471
[TBL] [Abstract][Full Text] [Related]
5. Influence of CR3 (CD11b/CD18) expression on phagocytosis of Bordetella pertussis by human neutrophils.
Mobberley-Schuman PS; Weiss AA
Infect Immun; 2005 Nov; 73(11):7317-23. PubMed ID: 16239529
[TBL] [Abstract][Full Text] [Related]
6. Pertussis toxin and lipopolysaccharide influence phagocytosis of Bordetella pertussis by human monocytes.
Schaeffer LM; Weiss AA
Infect Immun; 2001 Dec; 69(12):7635-41. PubMed ID: 11705943
[TBL] [Abstract][Full Text] [Related]
7. Phagocytosis of Bordetella pertussis incubated with convalescent serum.
Mobberley-Schuman PS; Connelly B; Weiss AA
J Infect Dis; 2003 May; 187(10):1646-53. PubMed ID: 12721945
[TBL] [Abstract][Full Text] [Related]
8. Bordetella pertussis lipopolysaccharide resists the bactericidal effects of pulmonary surfactant protein A.
Schaeffer LM; McCormack FX; Wu H; Weiss AA
J Immunol; 2004 Aug; 173(3):1959-65. PubMed ID: 15265930
[TBL] [Abstract][Full Text] [Related]
9. Pertussis toxin and extracytoplasmic adenylate cyclase as virulence factors of Bordetella pertussis.
Weiss AA; Hewlett EL; Myers GA; Falkow S
J Infect Dis; 1984 Aug; 150(2):219-22. PubMed ID: 6088647
[TBL] [Abstract][Full Text] [Related]
10. Targeted mutations that ablate either the adenylate cyclase or hemolysin function of the bifunctional cyaA toxin of Bordetella pertussis abolish virulence.
Gross MK; Au DC; Smith AL; Storm DR
Proc Natl Acad Sci U S A; 1992 Jun; 89(11):4898-902. PubMed ID: 1594590
[TBL] [Abstract][Full Text] [Related]
11. Interaction of Bordetella pertussis virulence components with neutrophils: effect on chemiluminescence induced by a chemotactic peptide and by intact bacteria.
Craig FF; Lackie JM; Parton R; Freer JH
J Gen Microbiol; 1988 Aug; 134(8):2201-11. PubMed ID: 2908118
[TBL] [Abstract][Full Text] [Related]
12. Intracellular survival of virulent Bordetella pertussis in human polymorphonuclear leukocytes.
Steed LL; Setareh M; Friedman RL
J Leukoc Biol; 1991 Oct; 50(4):321-30. PubMed ID: 1919361
[TBL] [Abstract][Full Text] [Related]
13. Invasive adenylate cyclase toxin of Bordetella pertussis.
Hanski E
Trends Biochem Sci; 1989 Nov; 14(11):459-63. PubMed ID: 2560273
[TBL] [Abstract][Full Text] [Related]
14. Both adenylate cyclase and hemolytic activities are required by Bordetella pertussis to initiate infection.
Khelef N; Sakamoto H; Guiso N
Microb Pathog; 1992 Mar; 12(3):227-35. PubMed ID: 1614333
[TBL] [Abstract][Full Text] [Related]
15. The Eukaryotic Host Factor 14-3-3 Inactivates Adenylate Cyclase Toxins of Bordetella bronchiseptica and B. parapertussis, but Not B. pertussis.
Fukui-Miyazaki A; Toshima H; Hiramatsu Y; Okada K; Nakamura K; Ishigaki K; Shinzawa N; Abe H; Horiguchi Y
mBio; 2018 Aug; 9(4):. PubMed ID: 30154257
[No Abstract] [Full Text] [Related]
16. Molecular aspects of Bordetella pertussis pathogenesis.
Locht C
Int Microbiol; 1999 Sep; 2(3):137-44. PubMed ID: 10943406
[TBL] [Abstract][Full Text] [Related]
17. Role of Major Toxin Virulence Factors in Pertussis Infection and Disease Pathogenesis.
Scanlon K; Skerry C; Carbonetti N
Adv Exp Med Biol; 2019; 1183():35-51. PubMed ID: 31376138
[TBL] [Abstract][Full Text] [Related]
18. Bordetella adenylate cyclase is a virulence associated factor and an immunoprotective antigen.
Guiso N; Rocancourt M; Szatanik M; Alonso JM
Microb Pathog; 1989 Nov; 7(5):373-80. PubMed ID: 2622329
[TBL] [Abstract][Full Text] [Related]
19. Cholesterol-rich domains are involved in Bordetella pertussis phagocytosis and intracellular survival in neutrophils.
Lamberti Y; Perez Vidakovics ML; van der Pol LW; Rodríguez ME
Microb Pathog; 2008 Jun; 44(6):501-11. PubMed ID: 18276103
[TBL] [Abstract][Full Text] [Related]
20. Antibodies to Bordetella pertussis adenylate cyclase toxin in neonatal and maternal sera.
Arciniega JL; Hewlett EL; Edwards KM; Burns DL
FEMS Immunol Med Microbiol; 1993 Apr; 6(4):325-30. PubMed ID: 8499896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
